UnknownPhase 3NCT00025402

Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia

Studying Atypical chronic myeloid leukemia

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: III. Medizinische Klinik Mannheim
Principal Investigator: Ruediger Hehlmann, MD
III. Medizinische Klinik Mannheim
Intervention: filgrastim(biological)
Enrollment: 1000 enrolled
Eligibility: All sexes
Timeline: 1997

Study locations (30)

Masaryk University Hospital, Brno, Czechia
Haematologisch Onkologische Praxis, Aachen, Germany
Kinderklinik - Universitaetsklinikum Aachen, Aachen, Germany
Urologische Klinik - Universitaetsklinikum Aachen, Aachen, Germany
Kreiskrankenhaus, Aalen, Germany
Klinikum St. Marien, Amberg, Germany
Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie, Ansbach, Germany
II. Medizinische Klinik, Aschaffenburg, Germany
Haematologische Praxis, Augsburg, Germany
Klinikum Augsburg, Augsburg, Germany
Kreiskrankenhaus, Bad Hersfeld, Germany
Krankenhaus Hohe Warte Mediziniche Klinik, Bayreuth, Germany
St. Hedwig Kranken Haus, Berlin, Germany
Tumorzentrum Berlin-Moabit, Berlin, Germany
Wenckebach - Krankenhaus, Berlin, Germany
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00025402 on ClinicalTrials.gov

Other trials for Atypical chronic myeloid leukemia

Additional recruiting or active studies for the same condition.

See all trials for Atypical chronic myeloid leukemia →

← Back to all trials